Currently Viewing:
Newsroom
Currently Reading
Bone Marrow Environment in Patients With RA May Promote Inflammation
December 12, 2017 – Kelly Davio
Researchers Say Medicare Advantage Plans Need Better Incentives to Meet Future Demand
December 12, 2017 – Allison Inserro
University, Genetics Firm Find Link Between ADHD, Delay Discounting
December 12, 2017 – Allison Inserro
Welltok Identifies Who's at Risk for Getting and Spreading the Flu
December 12, 2017 – Jaime Rosenberg
What We're Reading: Medical Device Approval; Medical Laboratories Sue Government; ACA Sign-Up Deadline
December 12, 2017 – AJMC Staff
What's the Magic Payment Mix for Medicare Primary Care Providers?
December 11, 2017 – Allison Inserro
Racial Disparities Prevalent in Survival of Patients With Ovarian, Colon, and Breast Cancer
December 11, 2017 – Jaime Rosenberg
Sanofi's Insulin Lispro Follow-On, Admelog, Wins FDA Approval
December 11, 2017 – Mary Caffrey
The Past, Present, and Future of HIV Funding
December 11, 2017 – Jaime Rosenberg

5 Aspects of Medical Malpractice in the United States

Laura Joszt
On Thursday, the House of Representatives passed a bill that would reform medical malpractice by capping noneconomic damages at $250,000. Supporters say the reform would reduce frivolous claims and prevent doctors from practicing costly defensive medicine. Here’s a look at 5 aspects of medical malpractice in the United States.
On Thursday, the House of Representatives passed a bill that would reform medical malpractice by capping noneconomic damages at $250,000. Supporters say the reform would reduce frivolous claims and prevent doctors from practicing costly defensive medicine.

Here’s a look at 5 aspects of medical malpractice in the United States.

1. State variety in malpractice

Typically, the states have more control over tort law, which is one reason why some Republicans don’t support the malpractice reform bill. As a result, states have varied widely in regulations and procedures for punishing wrongdoing among doctors. A study from the University of Michigan Medical School found that the percentage of doctors who are disciplined or pay a malpractice claim can be as much as 4 times less in some states compared with others.

This new bill would impose a federal standard on what is typically determined by states.

2. Malpractice prevents some physicians from cutting out low-value care

Physicians who have advocated for tort reform in the area of malpractice have argued that they practice defensive medicine, which can drive up costs as they order extra tests and take other defensive steps to avoid being sued.

The Choosing Wisely initiative aims to reduce unnecessary, expensive tests, but a study published in The American Journal of Managed Care® found that surgical specialists were more concerned about malpractice lawsuits than being cost conscious when providing care.

3. Cost of defensive care

Defensive medicine is considered the overuse of tests and procedures because of fear of malpractice litigation. There are estimates that put the cost of defensive medicine at $46 billion annually in the United States, and a report published in JAMA in 2014 studied 3 hospitals in Massachusetts to determine the cost of defensive medicine. The researchers found that more than one-fourth of patient orders were at least partially defensive medicine, but that they only accounted for 13% of hospital costs.

4. Communication is key

A report from CRICO found that 30% of malpractice cases filed between 2009 and 2013 cited some form of miscommunication. This miscommunication can occur between providers or between the provider and the patient. Common communication issues included a miscommunication about the patient’s condition, poor documentation, failure to read the medical record, and no/wrong results given to the patient.

5. Pathways drive lower cost care

One tool that is being used to combat malpractice suits is clinical pathways, which require detailed documentation of any deviation to avoid liability. For instance, a recent study in the Journal of Oncology Practice found that clinical pathways could successfully drive physicians to choose a less costly regimen when efficacy and toxicity of different treatment regimens for metastatic colorectal cancer are comparable.

 
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!